Action CBPI CHINA BOTANIC PHARMACEUTICAL INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues China Botanic Pharmaceutical Inc. Other OTC

Actions

CBPI

US16890Y1047

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Fuss Brands Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024
Fuss Brands Corp. Reports Earnings Results for the Full Year Ended October 31, 2023
Fuss Brands Corp. Announces Resignation of Issamar Ginzberg as Chief Executive Officer
Fuss Brands Corp. Announces Board Changes
Fuss Brands Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
Fuss Brands Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023
Fuss Brands Corp. Reports Earnings Results for the First Quarter Ended January 31, 2023
FUSS BRANDS CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT OF OPERATIONS (form 10-K)
Fuss Brands Corp. Reports Earnings Results for the Full Year Ended October 31, 2022
FUSS BRANDS CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
Fuss Brands Corp. Receives Purchase Order from Roomwagon, LLC
Fuss Brands Corp. Auditor Raises 'Going Concern' Doubt
Fuss Brands Corp. announced that it has received $0.078 million in funding
FUSS BRANDS CORP. Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K/A)
FUSS BRANDS CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Fuss Brands Corp. Signs Licensing Agreement with Anyvention Ltd. to Acquire Intellectual Property Rights
Fuss Brands Corp. Signs Licensing Agreement with Anyvention Ltd. to Acquire Intellectual Property Rights
FUSS BRANDS CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
FUSS BRANDS CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Fuss Brands Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action FBDS
  4. Action CBPI
  5. Actualités China Botanic Pharmaceutical Inc.
  6. Autres langues